View Future GrowthCBD Life Sciences 過去の業績過去 基準チェック /06CBD Life Sciencesの過去数年間の業績に関するデータが不十分です。主要情報n/a収益成長率n/aEPS成長率Pharmaceuticals 業界の成長5.95%収益成長率n/a株主資本利益率n/aネット・マージンn/a前回の決算情報31 Mar 2024最近の業績更新更新なしすべての更新を表示Recent updatesお知らせ • May 16CBD Life Sciences Inc. has filed a Follow-on Equity Offering in the amount of $0.448 million.CBD Life Sciences Inc. has filed a Follow-on Equity Offering in the amount of $0.448 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 4,000,000,000 Price\Range: $0.000112 Discount Per Security: $0お知らせ • Jan 07CBD Life Sciences, Inc. Secures Breakthrough Walmart Marketplace Approval for Mushroom Supplement, Setting the Stage for Unprecedented GrowthCBD Life Sciences Inc. announce that its Mushroom Madness Rise Gummies, featuring a powerful Lion's Mane mushroom blend, have officially been approved for sale and are now available on Walmart Marketplace. This monumental approval opens the door for CBDL to tap into Walmart's expansive e-commerce ecosystem, providing a pathway to substantial revenue growth while strengthening its position in the rapidly expanding functional mushroom market. The global functional mushroom market continues to surge, projected to reach $42.4 billion by 2028, with Lion's Mane products leading the charge due to their cognitive health benefits. CBDL's Mushroom Madness Rise Gummies, formulated for focus, clarity, and enhanced mental performance, are well-positioned to meet the increasing demand for natural wellness solutions. Walmart Marketplace, recognized as one of the fastest-growing online retail platforms, boasts over 100 million monthly visitors. With third-party sellers generating substantial portions of Walmart's e-commerce revenue, the platform offers unmatched scalability and visibility for emerging brands. CBDL's entry onto Walmart Marketplace provides logistical efficiencies, enhanced consumer trust, and a direct line to an enormous, ever-expanding customer base. Industry reports indicate that third-party sellers often experience double-digit sales growth within months of launching on Walmart Marketplace. This offers CBDL an unprecedented opportunity to scale its revenues rapidly, further bolstered by Walmart's robust digital marketing support and fulfillment network. CBD Life Sciences has already achieved impressive financial growth, recording a 1405.46% increase in revenue since February 2024. The company expects Walmart Marketplace to significantly enhance its revenue stream, given the rapid consumer adoption of functional mushroom products and CBD-infused supplements. The Mushroom Madness Rise Gummies are a strategic addition to CBDL's product lineup, aligning with the company's commitment to offering scientifically formulated, high-efficacy wellness products. These gummies not only serve a growing wellness market but also position CBDL to capture a significant share of the $20 billion U.S. supplement industry. As part of its long-term strategy, CBDL plans to launch additional top-selling products on Walmart Marketplace, including its highly anticipated nano-CBD supplements and mushroom-enhanced nutritional powders.お知らせ • Dec 03CBD Life Sciences Inc. Announces New Delta-8 100MG Gummies Designed to Support Individuals Living with Alzheimer'sCBD Life Sciences Inc. announced the launch of its groundbreaking Delta-8 100mg Gummies, specially formulated to support individuals living with Alzheimer's disease. These expertly crafted gummies offer gentle relief and enhanced well-being, addressing the unique needs of patients and their families navigating the challenges of neurodegenerative conditions. CBD Life Sciences' entry into this specialized segment of the $6 billion U.S. edibles market positions the company as a pioneer in creating products tailored to an underserved demographic. As the population ages and awareness of natural alternatives grows, Delta-8 products are rapidly gaining traction as effective solutions for managing symptoms associated with Alzheimer's and related conditions. A Product Born from Real Needs and Scientific Innovation: The development of these gummies is deeply rooted in the stories of CBD Life Sciences' clients, who shared how Delta-8 products have positively impacted their loved ones living with Alzheimer's. This heartfelt feedback spurred the creation of a product aimed at addressing symptoms such as anxiety, restlessness, agitation, and mood swings, all while promoting cognitive calmness and overall quality of life.Delta-8, a naturally occurring cannabinoid, is celebrated for its mild yet effective benefits. Unlike more aggressive treatments, Delta-8 provides a balance of support without overwhelming psychoactive effects, making it an ideal choice for seniors seeking natural relief. Revenue and Growth Potential: The Alzheimer's population in the United States is expected to exceed 12.7 million by 2050, creating a significant and growing demand for targeted wellness products. Early projections indicate that this product line could contribute an additional $3 million in revenue within its first year, as CBD Life Sciences continues to meet the rising interest in cannabinoid-based solutions for elderly care. The senior segment of the edibles market is rapidly emerging as a key growth area. A recent study reported a 300% increase in cannabinoid use among individuals aged 65 and older over the past decade. This demographic is increasingly turning to natural products like Delta-8 for their ability to support physical and cognitive health without the side effects often associated with pharmaceuticals. Meeting the Needs of an Underserved Market: CBD Life Sciences'Delta-8 Gummies are designed with seniors in mind. These gummies are made from all-natural ingredients, offering easy consumption, precise dosing, and a discreet form factor. Rigorous third-party testing ensures their purity, potency, and consistency, providing families and caregivers with confidence in their safety and efficacy. The gummies' formulation emphasizes cognitive support and emotional balance, helping to manage the everyday challenges of Alzheimer's while offering peace of mind to those providing care. CBD Life Sciences: Setting the Standard in Innovation: The launch of the Delta-8 Gummies for Alzheimer's marks another milestone in CBD Life Sciences' remarkable growth trajectory. Since February 2024, the company has achieved a 1405.46% increase in revenue, driven by its commitment to delivering high-quality, innovative products that resonate with consumers. This latest product also highlights the company's strategic focus on expanding its reach in the health and wellness sector, where demand for cannabinoid-based solutions continues to skyrocket. By addressing the specific needs of aging individuals and their families, CBD Life Sciences solidifies its position as a trusted leader in the industry.お知らせ • Nov 02CBD Life Sciences Inc. Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into A Booming $20 Billion MarketCBD Life Sciences Inc. sets a new industry standard with its launch of a high-performance line of mushroom-infused gummies, designed to meet the surging demand for wellness products in a projected $20 billion market. Focused on energy, sleep, and sexual wellness, these unique formulations offer CBDL shareholders and new investors an unprecedented growth opportunity in an exploration sector. With an expanding consumer focus on holistic health and functional ingredients, CBDL's Rise, Dream, and Bloom Gummies each bring targeted benefits, including cognitive enhancement, restful sleep, and boosted vitality. These products are strategically positioned to address top wellness priorities, blending potent natural ingredients with advanced formulation technology. This launch is expected to significantly contribute to CBDL's revenue stream, enhancing shareholder value and setting the company apart as an innovator in functional wellness. Rise Gummies are formulated to support focus and energy, each containing 500mg of Lion's Mane Mushroom, 1 microgram of B12, and 25mg of Ginseng. This combination aligns with a growing segment of consumers seeking natural solutions to boost mental clarity and productivity. Dream Gummies provide natural support for relaxation and sleep, with 500mg of Reishi Mushroom, 25mg of Kava, and 10mg of 5-HTP. With sleep wellness now a top priority for many, Dream Gummies offer a non-habit-forming solution to support stress relief and emotional balance. Bloom Gummies offer a targeted formula for sexual wellness and vitality, incorporating 500mg of Cordyceps Mushroom along with Tongkat Ali, Ginkgo Biloba, Ginseng, L-Arginine, Ashwagandha, and Maca. With its pioneering approach to wellness, CBDL is dedicated to securing sustained value for investors by remaining at the forefront of natural health innovation.お知らせ • Oct 03CBD Life Sciences, Inc. Launches CBD Horse PasteCBD Life Sciences Inc. announced the launch of its latest product, the CBD Horse Paste. This veterinarian-designed formulation is the first of its kind, offering unparalleled support for horses facing both physical and psychological challenges. Equine health concerns such as muscle stiffness, joint pain, and anxiety can significantly affect a horse's well-being. The CBD Horse Paste addresses these issues with a unique combination of cannabinoids and terpenes, providing an easy-to-administer solution that stays in the horse's mouth longer than CBD oils, ensuring maximum absorption. Each syringe delivers 500mg of premium CBD with a flavor horses love, making it ideal for stress-inducing situations like farrier visits or long trailer rides. Key Benefits of CBD Horse Paste: Veterinarian-Designed Formulation: Created by equine health experts for maximum effectiveness. Comprehensive Health Support: Eases muscle stiffness, joint issues, and stress-related behaviors like boredom and anxiety. Easy-to-Use: Each syringe contains four doses, making it convenient for horse owners. Delicious Flavor: The paste's flavor ensures horses readily accept it. Versatile Application: Perfect for use during stressful situations, such as travel, farrier visits, and training sessions. Innovative CBD for Equine Wellness: The CBD Horse Paste not only addresses common equine health concerns but also serves as a natural alternative to traditional calming agents and medications. By leveraging the powerful properties of CBD and terpenes, horses can experience relief from arthritis-induced stiffness and joint pain, as well as a reduction in anxiety caused by environmental changes, isolation, or past trauma.お知らせ • Sep 24CBD Life Sciences, Inc. Announces Expanding Revenue Stream with Walmart MarketplaceCBD Life Sciences Inc. announced the launch of its product line on Walmart Marketplace. This milestone marks a significant leap in retail strategy, poised to drive substantial revenue growth and expand market reach to millions of potential customers. Market Expansion: By entering the Walmart Marketplace, the company are now accessible to one of the largest retail platforms in the world, boasting over 120 million monthly visitors. This launch strategically positions CBDL to significantly increase brand visibility and consumer base. Revenue Growth: Early forecasts project a substantial revenue boost, with a projected increase of 35% in annual sales due to this new distribution channel. The company revenue growth over the past 12 months has already seen a 20% rise, and the company expects accelerated growth driven by this expansion. Product Line on Walmart: The initial offerings will include top-selling Nano CBD Coffee Creamer, Mellow Mornings, and CBD Pain Cream, which have seen growing demand in local markets. These products, praised for their effectiveness, will now have national distribution, broadening customer base across the U.S. Investor Impact: This move opens additional streams of revenue that will enhance shareholder value. By diversifying sales channels, the company aim to increase its gross margins by 10% while driving stronger returns for investors over the next fiscal year. A Proven Path to Growth: As a small but rapidly growing company, the company recognize that entering high-traffic marketplaces like Walmart is a powerful catalyst for scaling. The company continue to prioritize innovation in product lines and have seen positive feedback from both consumers and local retailers. With products now on Walmart Marketplace, the company anticipates a robust competitive edge and a much larger footprint in the booming CBD sector, which is projected to reach $47.22 billion by 2028.お知らせ • Sep 18CBD Life Sciences, Inc. Unveils Groundbreaking Nutritional Supplement Infused with Mushroom Extracts, Set to Drive Revenue and Revolutionize WellnessCBD Life Sciences Inc. launched a cutting-edge nutritional supplement powder designed to harness the powerful health benefits of natural ingredients. This new supplement contains a proprietary blend of reishi mushroom extract, lion's mane mushroom extract, and ashwagandha root extract, offering an integrated approach to wellness by reducing stress, supporting brain health, and enhancing the immune system. Recent studies highlight the effectiveness of reishi extract, not only in boosting the immune system but also in slowing or stopping tumor growth, a feature that positions this product as an essential addition to the wellness market. The blend of lion's mane extract and ashwagandha root provides additional cognitive support and anti-inflammatory benefits, making it an all-around solution for physical and mental well-being. Unrivaled Benefits of Key Ingredients: Reishi Mushroom Extract: Renowned for its immune-boosting and anti-cancer properties, research suggests it can slow tumor growth, making it one of the most potent natural supplements available today. Lion's Mane Mushroom Extract: Known for supporting brain health, lion's mane helps to enhance cognitive function and promote nerve regeneration, ideal for those seeking long-term mental clarity. Ashwagandha Root Extract: Widely celebrated for reducing stress and its anti-inflammatory effects, ashwagandha contributes to overall mental health and physical recovery. Revenue Projections & Market Potential.With the global supplement market experiencing rapid growth, the introduction of this new product is projected to significantly boost CBD Life Sciences Inc.'s annual revenue. Analystsexpect the market for mushroom-infused supplements to reach $18 billion by 2028, and with the unique blend of ingredients in this product, CBD Life Sciences Inc. is poised to capture a substantial portion of that market. This launch is expected to drive a revenue increase of 20% within the first year, positioning the company at the forefront of the wellness supplement industry.お知らせ • Sep 05CBD Life Sciences Inc. Unveils Mellow MorningsCBD Life Sciences Inc. announced the launch of its latest innovation, Mellow Mornings, a nano CBD Coffee Creamer poised to disrupt the burgeoning CBD coffee market. Available in Pumpkin Spice Cheesecake, Pumpkin, Vanilla and Classic flavors, each bottle of Mellow Mornings contains 1000mg of CBD, offering a powerful, flavorful, and health-boosting addition to daily coffee routine. Riding the Wave of a Growing Market: The CBD coffee market is experiencing rapid growth nationwide, with consumers increasingly seeking out wellness-oriented products that seamlessly integrate into their daily lives. Industry reports project the CBD-infused beverage market to reach $2.6 billion by 2025, driven by the rising popularity of functional beverages. Mellow Mornings is strategically positioned to capitalize on this trend, offering a unique product that combines the comforting ritual of coffee with the therapeutic benefits of CBD. Significant Revenue Potential: Mellow Mornings represents a substantial revenue opportunity for CBD Life Sciences Inc. With the nationwide growth of CBD coffee, the company projects that this new product could add up to $2 million in annual revenue within its first year of launch. This estimate is based on anticipated sales from both direct-to-consumer channels and partnerships with coffee shops and retailers across the country. Revolutionary CBD Delivery for Maximum Efficacy: Leveraging cutting-edge nanotechnology, Mellow Mornings offers superior bioavailability, ensuring that the CBD is absorbed more efficiently by the body. This means that consumers can experience the calming and wellness benefits of CBD more effectively than with traditional formulations. Each bottle of Mellow Mornings is up to 10 times more effective, making it a standout product in a crowded market. Adoption by Local Coffee Shops: Mellow Mornings has already garnered attention from local coffee shops, where it is being used to create specialty CBD Lattes and other beverages. This early adoption is a testament to the product's quality and potential to become a staple in the CBD coffee market.お知らせ • Jul 10CBD Life Sciences Inc. Through Its Wholly Owned Subsidiary, The CBD Vault Inc. Launches New Line of Kava & Kratom ShotsCBD Life Sciences Inc. through its wholly owned subsidiary, The CBD Vault Inc. announced the launch of its new line of Kava & Kratom shots. Designed to provide a natural boost of energy and relaxation, these shots are the latest addition to the company's innovative product lineup. Product Highlights: Natural Ingredients: Kava & Kratom shots are crafted using the highest quality natural ingredients, ensuring a safe and effective experience. Convenient & Portable: Packaged in a sleek, portable bottle, these shots are perfect for on-the-go use, making it easy to enjoy their benefits anytime, anywhere. Balanced Formulation: The carefully balanced blend of Kava and Kratom provides a harmonious mix of relaxation and energy, helping stay focused and calm throughout the day. Great Taste: Available in a delicious apple flavor, shots are as enjoyable to drink as they are effective. Kava and Kratom are two powerful botanicals known for their unique properties. Kava, traditionally used in Pacific Island cultures, is renowned for its calming effects, while Kratom, native to Southeast Asia, is celebrated for its stimulating and pain-relieving properties. Together, they offer a synergistic effect that supports both mental and physical well-being.お知らせ • May 03CBD Life Sciences Inc. has filed a Follow-on Equity Offering.CBD Life Sciences Inc. has filed a Follow-on Equity Offering. Security Name: Common Stock Security Type: Common Stock Securities Offered: 3,000,000,000お知らせ • Jan 12CBD Life Sciences Inc. Launches Premium Terpene Infused OilCBD Life Sciences through its wholly owned subsidiary, LBC Bioscience Inc. announced that the company developed new CBD Oil infused with top-of-the-line terpenes and will be available to purchase in the next couple of days on LBC Bioscience Inc.'s website. LBC Bioscience Inc. has recently established a manufacturing facility for product development along with other operations, and the company has formulated a Premium Non-GMO tincture coming in strengths of 500MG, 1500MG, & 3000MG! This tincture will come in 14 different flavors and will be packed with some of the best terpenes on the market today. LBC Bioscience's all-new powerhouse product boasts rapid absorption, four times the potency of other hemp-derived tinctures and stronger than any products the company currently carries. Its high-quality ingredient combination has shown impressive results with satisfaction following the sampling process. LBC's new tincture is focused on assisting muscle discomfort, stress, and sleep deprivation. All products made by LBC Bioscience are carefully blended to ensure maximum consistency along with top-tier Third Party Lab Testing for verification. In 2023, LBC Bioscience Inc. will continue to strive to improve its customers' daily lives with high-quality premium products that are not only easily accessible, but affordable.収支内訳CBD Life Sciences の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史OTCPK:CBDL 収益、費用、利益 ( )USD Millions日付収益収益G+A経費研究開発費31 Mar 24000031 Dec 23000031 Mar 230-11031 Dec 220-11030 Jun 220-33031 Mar 220-55031 Dec 210-66030 Sep 210-55031 Dec 200-21030 Sep 200-20031 Dec 190-10030 Sep 190-31030 Jun 190-31031 Mar 191-31031 Dec 181-31031 Dec 173110質の高い収益: CBDLが 高品質の収益 を有しているかどうかを判断するにはデータが不十分です。利益率の向上: CBDLの 利益率 が過去 1 年間で改善したかどうかを判断するにはデータが不十分です。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: CBDLの過去 5 年間の前年比収益成長率がプラスであったかどうかを判断するにはデータが不十分です。成長の加速: CBDLの過去 1 年間の収益成長を 5 年間の平均と比較するにはデータが不十分です。収益対業界: CBDLの過去 1 年間の収益成長がPharmaceuticals業界平均を上回ったかどうかを判断するにはデータが不十分です。株主資本利益率高いROE: CBDLは現在利益が出ていないため、自己資本利益率 ( 0% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 04:04終値2026/05/22 00:00収益2024/03/31年間収益2023/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋CBD Life Sciences Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 16CBD Life Sciences Inc. has filed a Follow-on Equity Offering in the amount of $0.448 million.CBD Life Sciences Inc. has filed a Follow-on Equity Offering in the amount of $0.448 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 4,000,000,000 Price\Range: $0.000112 Discount Per Security: $0
お知らせ • Jan 07CBD Life Sciences, Inc. Secures Breakthrough Walmart Marketplace Approval for Mushroom Supplement, Setting the Stage for Unprecedented GrowthCBD Life Sciences Inc. announce that its Mushroom Madness Rise Gummies, featuring a powerful Lion's Mane mushroom blend, have officially been approved for sale and are now available on Walmart Marketplace. This monumental approval opens the door for CBDL to tap into Walmart's expansive e-commerce ecosystem, providing a pathway to substantial revenue growth while strengthening its position in the rapidly expanding functional mushroom market. The global functional mushroom market continues to surge, projected to reach $42.4 billion by 2028, with Lion's Mane products leading the charge due to their cognitive health benefits. CBDL's Mushroom Madness Rise Gummies, formulated for focus, clarity, and enhanced mental performance, are well-positioned to meet the increasing demand for natural wellness solutions. Walmart Marketplace, recognized as one of the fastest-growing online retail platforms, boasts over 100 million monthly visitors. With third-party sellers generating substantial portions of Walmart's e-commerce revenue, the platform offers unmatched scalability and visibility for emerging brands. CBDL's entry onto Walmart Marketplace provides logistical efficiencies, enhanced consumer trust, and a direct line to an enormous, ever-expanding customer base. Industry reports indicate that third-party sellers often experience double-digit sales growth within months of launching on Walmart Marketplace. This offers CBDL an unprecedented opportunity to scale its revenues rapidly, further bolstered by Walmart's robust digital marketing support and fulfillment network. CBD Life Sciences has already achieved impressive financial growth, recording a 1405.46% increase in revenue since February 2024. The company expects Walmart Marketplace to significantly enhance its revenue stream, given the rapid consumer adoption of functional mushroom products and CBD-infused supplements. The Mushroom Madness Rise Gummies are a strategic addition to CBDL's product lineup, aligning with the company's commitment to offering scientifically formulated, high-efficacy wellness products. These gummies not only serve a growing wellness market but also position CBDL to capture a significant share of the $20 billion U.S. supplement industry. As part of its long-term strategy, CBDL plans to launch additional top-selling products on Walmart Marketplace, including its highly anticipated nano-CBD supplements and mushroom-enhanced nutritional powders.
お知らせ • Dec 03CBD Life Sciences Inc. Announces New Delta-8 100MG Gummies Designed to Support Individuals Living with Alzheimer'sCBD Life Sciences Inc. announced the launch of its groundbreaking Delta-8 100mg Gummies, specially formulated to support individuals living with Alzheimer's disease. These expertly crafted gummies offer gentle relief and enhanced well-being, addressing the unique needs of patients and their families navigating the challenges of neurodegenerative conditions. CBD Life Sciences' entry into this specialized segment of the $6 billion U.S. edibles market positions the company as a pioneer in creating products tailored to an underserved demographic. As the population ages and awareness of natural alternatives grows, Delta-8 products are rapidly gaining traction as effective solutions for managing symptoms associated with Alzheimer's and related conditions. A Product Born from Real Needs and Scientific Innovation: The development of these gummies is deeply rooted in the stories of CBD Life Sciences' clients, who shared how Delta-8 products have positively impacted their loved ones living with Alzheimer's. This heartfelt feedback spurred the creation of a product aimed at addressing symptoms such as anxiety, restlessness, agitation, and mood swings, all while promoting cognitive calmness and overall quality of life.Delta-8, a naturally occurring cannabinoid, is celebrated for its mild yet effective benefits. Unlike more aggressive treatments, Delta-8 provides a balance of support without overwhelming psychoactive effects, making it an ideal choice for seniors seeking natural relief. Revenue and Growth Potential: The Alzheimer's population in the United States is expected to exceed 12.7 million by 2050, creating a significant and growing demand for targeted wellness products. Early projections indicate that this product line could contribute an additional $3 million in revenue within its first year, as CBD Life Sciences continues to meet the rising interest in cannabinoid-based solutions for elderly care. The senior segment of the edibles market is rapidly emerging as a key growth area. A recent study reported a 300% increase in cannabinoid use among individuals aged 65 and older over the past decade. This demographic is increasingly turning to natural products like Delta-8 for their ability to support physical and cognitive health without the side effects often associated with pharmaceuticals. Meeting the Needs of an Underserved Market: CBD Life Sciences'Delta-8 Gummies are designed with seniors in mind. These gummies are made from all-natural ingredients, offering easy consumption, precise dosing, and a discreet form factor. Rigorous third-party testing ensures their purity, potency, and consistency, providing families and caregivers with confidence in their safety and efficacy. The gummies' formulation emphasizes cognitive support and emotional balance, helping to manage the everyday challenges of Alzheimer's while offering peace of mind to those providing care. CBD Life Sciences: Setting the Standard in Innovation: The launch of the Delta-8 Gummies for Alzheimer's marks another milestone in CBD Life Sciences' remarkable growth trajectory. Since February 2024, the company has achieved a 1405.46% increase in revenue, driven by its commitment to delivering high-quality, innovative products that resonate with consumers. This latest product also highlights the company's strategic focus on expanding its reach in the health and wellness sector, where demand for cannabinoid-based solutions continues to skyrocket. By addressing the specific needs of aging individuals and their families, CBD Life Sciences solidifies its position as a trusted leader in the industry.
お知らせ • Nov 02CBD Life Sciences Inc. Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into A Booming $20 Billion MarketCBD Life Sciences Inc. sets a new industry standard with its launch of a high-performance line of mushroom-infused gummies, designed to meet the surging demand for wellness products in a projected $20 billion market. Focused on energy, sleep, and sexual wellness, these unique formulations offer CBDL shareholders and new investors an unprecedented growth opportunity in an exploration sector. With an expanding consumer focus on holistic health and functional ingredients, CBDL's Rise, Dream, and Bloom Gummies each bring targeted benefits, including cognitive enhancement, restful sleep, and boosted vitality. These products are strategically positioned to address top wellness priorities, blending potent natural ingredients with advanced formulation technology. This launch is expected to significantly contribute to CBDL's revenue stream, enhancing shareholder value and setting the company apart as an innovator in functional wellness. Rise Gummies are formulated to support focus and energy, each containing 500mg of Lion's Mane Mushroom, 1 microgram of B12, and 25mg of Ginseng. This combination aligns with a growing segment of consumers seeking natural solutions to boost mental clarity and productivity. Dream Gummies provide natural support for relaxation and sleep, with 500mg of Reishi Mushroom, 25mg of Kava, and 10mg of 5-HTP. With sleep wellness now a top priority for many, Dream Gummies offer a non-habit-forming solution to support stress relief and emotional balance. Bloom Gummies offer a targeted formula for sexual wellness and vitality, incorporating 500mg of Cordyceps Mushroom along with Tongkat Ali, Ginkgo Biloba, Ginseng, L-Arginine, Ashwagandha, and Maca. With its pioneering approach to wellness, CBDL is dedicated to securing sustained value for investors by remaining at the forefront of natural health innovation.
お知らせ • Oct 03CBD Life Sciences, Inc. Launches CBD Horse PasteCBD Life Sciences Inc. announced the launch of its latest product, the CBD Horse Paste. This veterinarian-designed formulation is the first of its kind, offering unparalleled support for horses facing both physical and psychological challenges. Equine health concerns such as muscle stiffness, joint pain, and anxiety can significantly affect a horse's well-being. The CBD Horse Paste addresses these issues with a unique combination of cannabinoids and terpenes, providing an easy-to-administer solution that stays in the horse's mouth longer than CBD oils, ensuring maximum absorption. Each syringe delivers 500mg of premium CBD with a flavor horses love, making it ideal for stress-inducing situations like farrier visits or long trailer rides. Key Benefits of CBD Horse Paste: Veterinarian-Designed Formulation: Created by equine health experts for maximum effectiveness. Comprehensive Health Support: Eases muscle stiffness, joint issues, and stress-related behaviors like boredom and anxiety. Easy-to-Use: Each syringe contains four doses, making it convenient for horse owners. Delicious Flavor: The paste's flavor ensures horses readily accept it. Versatile Application: Perfect for use during stressful situations, such as travel, farrier visits, and training sessions. Innovative CBD for Equine Wellness: The CBD Horse Paste not only addresses common equine health concerns but also serves as a natural alternative to traditional calming agents and medications. By leveraging the powerful properties of CBD and terpenes, horses can experience relief from arthritis-induced stiffness and joint pain, as well as a reduction in anxiety caused by environmental changes, isolation, or past trauma.
お知らせ • Sep 24CBD Life Sciences, Inc. Announces Expanding Revenue Stream with Walmart MarketplaceCBD Life Sciences Inc. announced the launch of its product line on Walmart Marketplace. This milestone marks a significant leap in retail strategy, poised to drive substantial revenue growth and expand market reach to millions of potential customers. Market Expansion: By entering the Walmart Marketplace, the company are now accessible to one of the largest retail platforms in the world, boasting over 120 million monthly visitors. This launch strategically positions CBDL to significantly increase brand visibility and consumer base. Revenue Growth: Early forecasts project a substantial revenue boost, with a projected increase of 35% in annual sales due to this new distribution channel. The company revenue growth over the past 12 months has already seen a 20% rise, and the company expects accelerated growth driven by this expansion. Product Line on Walmart: The initial offerings will include top-selling Nano CBD Coffee Creamer, Mellow Mornings, and CBD Pain Cream, which have seen growing demand in local markets. These products, praised for their effectiveness, will now have national distribution, broadening customer base across the U.S. Investor Impact: This move opens additional streams of revenue that will enhance shareholder value. By diversifying sales channels, the company aim to increase its gross margins by 10% while driving stronger returns for investors over the next fiscal year. A Proven Path to Growth: As a small but rapidly growing company, the company recognize that entering high-traffic marketplaces like Walmart is a powerful catalyst for scaling. The company continue to prioritize innovation in product lines and have seen positive feedback from both consumers and local retailers. With products now on Walmart Marketplace, the company anticipates a robust competitive edge and a much larger footprint in the booming CBD sector, which is projected to reach $47.22 billion by 2028.
お知らせ • Sep 18CBD Life Sciences, Inc. Unveils Groundbreaking Nutritional Supplement Infused with Mushroom Extracts, Set to Drive Revenue and Revolutionize WellnessCBD Life Sciences Inc. launched a cutting-edge nutritional supplement powder designed to harness the powerful health benefits of natural ingredients. This new supplement contains a proprietary blend of reishi mushroom extract, lion's mane mushroom extract, and ashwagandha root extract, offering an integrated approach to wellness by reducing stress, supporting brain health, and enhancing the immune system. Recent studies highlight the effectiveness of reishi extract, not only in boosting the immune system but also in slowing or stopping tumor growth, a feature that positions this product as an essential addition to the wellness market. The blend of lion's mane extract and ashwagandha root provides additional cognitive support and anti-inflammatory benefits, making it an all-around solution for physical and mental well-being. Unrivaled Benefits of Key Ingredients: Reishi Mushroom Extract: Renowned for its immune-boosting and anti-cancer properties, research suggests it can slow tumor growth, making it one of the most potent natural supplements available today. Lion's Mane Mushroom Extract: Known for supporting brain health, lion's mane helps to enhance cognitive function and promote nerve regeneration, ideal for those seeking long-term mental clarity. Ashwagandha Root Extract: Widely celebrated for reducing stress and its anti-inflammatory effects, ashwagandha contributes to overall mental health and physical recovery. Revenue Projections & Market Potential.With the global supplement market experiencing rapid growth, the introduction of this new product is projected to significantly boost CBD Life Sciences Inc.'s annual revenue. Analystsexpect the market for mushroom-infused supplements to reach $18 billion by 2028, and with the unique blend of ingredients in this product, CBD Life Sciences Inc. is poised to capture a substantial portion of that market. This launch is expected to drive a revenue increase of 20% within the first year, positioning the company at the forefront of the wellness supplement industry.
お知らせ • Sep 05CBD Life Sciences Inc. Unveils Mellow MorningsCBD Life Sciences Inc. announced the launch of its latest innovation, Mellow Mornings, a nano CBD Coffee Creamer poised to disrupt the burgeoning CBD coffee market. Available in Pumpkin Spice Cheesecake, Pumpkin, Vanilla and Classic flavors, each bottle of Mellow Mornings contains 1000mg of CBD, offering a powerful, flavorful, and health-boosting addition to daily coffee routine. Riding the Wave of a Growing Market: The CBD coffee market is experiencing rapid growth nationwide, with consumers increasingly seeking out wellness-oriented products that seamlessly integrate into their daily lives. Industry reports project the CBD-infused beverage market to reach $2.6 billion by 2025, driven by the rising popularity of functional beverages. Mellow Mornings is strategically positioned to capitalize on this trend, offering a unique product that combines the comforting ritual of coffee with the therapeutic benefits of CBD. Significant Revenue Potential: Mellow Mornings represents a substantial revenue opportunity for CBD Life Sciences Inc. With the nationwide growth of CBD coffee, the company projects that this new product could add up to $2 million in annual revenue within its first year of launch. This estimate is based on anticipated sales from both direct-to-consumer channels and partnerships with coffee shops and retailers across the country. Revolutionary CBD Delivery for Maximum Efficacy: Leveraging cutting-edge nanotechnology, Mellow Mornings offers superior bioavailability, ensuring that the CBD is absorbed more efficiently by the body. This means that consumers can experience the calming and wellness benefits of CBD more effectively than with traditional formulations. Each bottle of Mellow Mornings is up to 10 times more effective, making it a standout product in a crowded market. Adoption by Local Coffee Shops: Mellow Mornings has already garnered attention from local coffee shops, where it is being used to create specialty CBD Lattes and other beverages. This early adoption is a testament to the product's quality and potential to become a staple in the CBD coffee market.
お知らせ • Jul 10CBD Life Sciences Inc. Through Its Wholly Owned Subsidiary, The CBD Vault Inc. Launches New Line of Kava & Kratom ShotsCBD Life Sciences Inc. through its wholly owned subsidiary, The CBD Vault Inc. announced the launch of its new line of Kava & Kratom shots. Designed to provide a natural boost of energy and relaxation, these shots are the latest addition to the company's innovative product lineup. Product Highlights: Natural Ingredients: Kava & Kratom shots are crafted using the highest quality natural ingredients, ensuring a safe and effective experience. Convenient & Portable: Packaged in a sleek, portable bottle, these shots are perfect for on-the-go use, making it easy to enjoy their benefits anytime, anywhere. Balanced Formulation: The carefully balanced blend of Kava and Kratom provides a harmonious mix of relaxation and energy, helping stay focused and calm throughout the day. Great Taste: Available in a delicious apple flavor, shots are as enjoyable to drink as they are effective. Kava and Kratom are two powerful botanicals known for their unique properties. Kava, traditionally used in Pacific Island cultures, is renowned for its calming effects, while Kratom, native to Southeast Asia, is celebrated for its stimulating and pain-relieving properties. Together, they offer a synergistic effect that supports both mental and physical well-being.
お知らせ • May 03CBD Life Sciences Inc. has filed a Follow-on Equity Offering.CBD Life Sciences Inc. has filed a Follow-on Equity Offering. Security Name: Common Stock Security Type: Common Stock Securities Offered: 3,000,000,000
お知らせ • Jan 12CBD Life Sciences Inc. Launches Premium Terpene Infused OilCBD Life Sciences through its wholly owned subsidiary, LBC Bioscience Inc. announced that the company developed new CBD Oil infused with top-of-the-line terpenes and will be available to purchase in the next couple of days on LBC Bioscience Inc.'s website. LBC Bioscience Inc. has recently established a manufacturing facility for product development along with other operations, and the company has formulated a Premium Non-GMO tincture coming in strengths of 500MG, 1500MG, & 3000MG! This tincture will come in 14 different flavors and will be packed with some of the best terpenes on the market today. LBC Bioscience's all-new powerhouse product boasts rapid absorption, four times the potency of other hemp-derived tinctures and stronger than any products the company currently carries. Its high-quality ingredient combination has shown impressive results with satisfaction following the sampling process. LBC's new tincture is focused on assisting muscle discomfort, stress, and sleep deprivation. All products made by LBC Bioscience are carefully blended to ensure maximum consistency along with top-tier Third Party Lab Testing for verification. In 2023, LBC Bioscience Inc. will continue to strive to improve its customers' daily lives with high-quality premium products that are not only easily accessible, but affordable.